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Abstract.  The insulin-regulated  adipocyte/skeletal 
muscle glucose transporter  (GLUT4) displays a char- 
acteristic steady-state intracellular  localization under 
basal conditions,  whereas the erythrocyte/brain trans- 
porter isoform (GLUTI) distributes mostly to the cell 
surface.  To identify possible structural  elements in 
these transporter proteins that determine their cellular 
localization,  GLUT1/GLUT4 chimera eDNA con- 
structs that contain the hemagglutinin  epitope 
YPYDVPDYA (HA) in their major exofacial loops 
were engineered.  Binding of monoclonal anti-HA anti- 
body to non-permeabilized COS-7 cells expressing 
HA-tagged transporter chimeras revealed that expres- 
sion of transporters on the cell surface was strongly 
influenced by their cytoplasmic COOH-terminal do- 
main.  This method also revealed a less marked, but 
significant effect on cellular localization of amino acid 
residues between transporter exofacial and middle 
loops. The subcellular distribution of expressed 
chimeras was confirmed by immunofluorescence mi- 
croscopy of permeabilized COS-7 cells. Thus,  HA- 
tagged native GLUT4 was concentrated in the 
perinuclear region,  whereas a chimera containing  the 
COOH-terminal 29 residues of GLUT1  substituted 
onto GLUT4 distributed to the plasma membrane,  as 
did native GLUT1. Furthermore,  a chimera composed 
of GLUT1 with a GLUT4 COOH-terminal 30-residue 
substitution exhibited a predominantly intracellular  lo- 
calization.  Similar data was obtained in CHO cells 
stably expressing these chimeras.  Taken together,  these 
results define the unique COOH-terminal cytoplasmic 
sequences of the GLUT1 and GLUT4 glucose trans- 
porters as important determinants  of cellular localiza- 
tion in COS-'/and CHO cells. 
LUCOSE entry into eucaryotic ceils is catalyzed by a 
group of glucose transporter protein isoforms that 
exhibit  •50%  sequence identity  relative  to  each 
other (reviewed in Gould and Bell, 1990). Much of the struc- 
tural similarity  among these transporters resides in 12 puta- 
tive  transmembrane  sequences.  In  contrast,  the  more 
hydrophilic  putative cytoplasmic and extracellular  domains 
contain sequences unique to each isoform.  It is thought that 
these latter regions might define divergent kinetic properties 
of transport  catalysis,  unique  regulatory  mechanisms,  or 
membrane targeting  signals.  Some of these transporter pro- 
teins are restricted to certain tissues, while others are widely 
distributed. For example, GLUT2 is present mostly in liver, 
kidney, small intestine,  and ~ cells of the pancreas (Bell et 
al.,  1990),  whereas  GLUT4  is  found  exclusively  in  the 
insulin-sensitive  tissues muscle and fat (Birnbaum  et al., 
1989; James et al.,  1989; Charron et al., 1989; Kaestner et 
al., 1989; Fukumoto et al., 1989). GLUT1 on the other hand 
is expressed to some extent in most if not all tissues.  Thus, 
the divergent tissue distribution patterns of the glucose trans- 
porter isoforms reinforce the concept that important differ- 
ences in function characterize these proteins. 
The position of cellular glucose uptake as the first step in 
the important process of sugar metabolism suggests that the 
transporter  proteins are highly  regulated.  Mechanisms  of 
regulation appear to include control of transporter gene tran- 
scription (Sivitz et al.,  1989), transporter protein degrada- 
tion (Haspel et al., 1986), catalytic activity (Harrison et al., 
1992), and cell surface localization (Cushman and Wardzala, 
1980; Suzuki and Kono, 1980). Muscle and fat cells exhibit 
a particularly striking acute stimulation  of glucose transport 
rates in response to the hormone insulin.  This response is 
mostly due to the catalytic activity of GLUT4 transporter 
proteins which are rapidly redistributed by insulin action to 
the cell surface membrane from a predominantly intracellu- 
lar localization in the basal state (Zorzano et al., 1989; Har- 
rison  et  al.,  1991). Evidence available  suggests  that  the 
GLUT4 proteins in non-stimulated  cells are mostly present 
in trans-Golgi (Slot et al., 1991) or other intracellular  vesic- 
ular structures (Smith et al., 1991). GLUT1 transporters are 
also present in these cells, but at a much lower concentra- 
tion. The GLUTI transporter proteins are already present at 
the cell surface to a significant degree in the basal state, al- 
though their further concentration  at the plasma membrane 
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al., 1990a). Recent evidence suggests that the intrinsic cata- 
lytic  activity of GLUT1  proteins  on  the  cell  surface  is 
markedly suppressed upon differentiation of 3T3-L1  fibro- 
blasts  in  culture  to  adipocytes (Harrison  et  al.,.  1991a; 
Czech et al., 1992), and that this can be released by insulin 
and other agents (Harrison et al., 1990b,  1991b). Taken to- 
gether, these observations indicate that GLUT1 and GLUT4 
may be the primary targets of different regulatory pathways. 
Recent studies have attempted to define structural ele- 
ments in the GLUT4 and GLUT1 transporter isoforms that 
determine their  divergent steady-state cellular membrane 
distributions (Piper et al., 1992; Asano et al., 1992). These 
experiments have led to remarkably divergent results and 
conclusions  among  different  laboratories.  For  example, 
Piper et al. (1992) have reported a highly significant effect 
of the NH2-terminal region of GLUT4 in governing the in- 
traceUular  disposition of chimera  GLUT4/GLUTI  trans- 
porter proteins expressed in CHO cells. These results were 
obtained using EM and immunofluorescence microscopy to 
detect cellular localization of glucose transporter chimera 
constructs. In contrast, Asano et al. (1992) reported that the 
membrane distribution of GLUT1/GLUT4 chimera proteins 
expressed in CHO cells did not reflect the presence or ab- 
sence of NH2-terminal sequences, but rather coincided with 
two regions located on either side of the middle loop of the 
glucose transporter structure. An additive effect to cause in- 
tracellular localization of transporter proteins by these two 
regions of GLUT4 were  noted when substituted into the 
GLUT1 transporter structure (Asano et al., 1992).  At pres- 
ent, it is not possible to ascribe the differences in results of 
these experiments to obvious explanations. 
The aim of the present studies was to develop novel meth- 
odology for assessing  structural  elements of the  glucose 
transporter proteins that determine steady-state cell surface 
versus intracellular distribution. In particular, we sought a 
technique  to  rigorously  establish  the  presence  of trans- 
porters at the cell surface as an alternative to standard im- 
munofluorescence microscopy. The results presented here 
demonstrate the effectiveness of a newly devised technique 
based on the insertion of a nine amino acid residue hemag- 
glutinin  (HA) ~ epitope  in  the  exofacial  loop  of glucose 
transporter proteins.  This is accomplished by engineering 
DNA encoding this epitope into native and GLUT1/GLUT4 
chimera constructs, expressing the tagged chimera proteins 
in COS-7 or CHO cells, and monitoring the binding of high 
affinity  anti-HA  epitope  antibody  to  these  fixed,  non- 
permeabilized cells. Data obtained by this new method, as 
well as by the usual immunofluorescence microscopy tech- 
niques, reveal that the major determinant of glucose trans- 
porter localization to cell surface versus intraceUular mem- 
branes resides in the unique COOH-terminal cytoplasmic 
sequences of the transporter proteins. 
Materials and Methods 
Cell Culture 
COS-7 and CHO-K1 cells were obtained from American Type Culture Col- 
lection (Rockville, MD). Media, trypsin, antibiotics, and G418 were from 
GIBCO/BRL (Gaithersburg, MD) and FBS was purchased from Upstate 
1. Abbreviation used in this paper:  HA, hemagglutinin. 
Biotechnology, Inc. (Lake Placid, NY).  COS-7 cells were maintained in 
DME with 10% FBS, 50 U/ml penicillin, and 50 t~g/ml streptomycin in a 
37°C humidified CO2 incubator. The cells were subeultured before reach- 
ing confluence. CHO-K1 cell lines were maintained in Ham's F-12 medium 
with 10% FBS, 50 U/ml penicillin, and 50/~g/ml streptomycin in a 37"C 
humidified CO2 incubator. 
Construction of  HA-tagged Chimera Transporters 
The cloning of the HepG2 GLUT1 eDNA was described previously (Harri- 
son et al. 1990b). The full-length eDNA for GLUT4 was cloned from a rat 
skeletal muscle eDNA library. All initial constructions were carded out in 
pUC18 or pUC19. 
The construction of untagged chimeras was undertaken in a similar man- 
ner to the construction of chimeras 1(1-199)/4 and 1(1-462)/4 described pre- 
viously (Pessino et al.,  1990).  Convenient existing restriction sites were 
used to switch domains between the two transporter isoforms whenever pos- 
sible. When existing restriction sites could not be found, new ones were 
made by site-directed mutagenesis such that the amino acid sequence was 
not altered. All of the constructions were confirmed by sequencing through 
the changed areas. The HA tag was inserted in the NH2 terminus or exofa- 
cial loop of GLUT1  and GLUT4 using oligonucleotides encoding the se- 
quences detailed below and having convenient restriction sites on the ends 
such that the tag could be inserted at the desired position in the protein. 
When necessary, HA tag insertions were carried out in subeloned fragments 
of the eDNA and the full length regenerated after insertion of the tag was 
confirmed by sequencing. Once the tag was inserted in the exofacial loop 
of the wild type transporters, these domains were swapped appropriately 
with the corresponding domains of the untagged chimera transporters to 
generate exofacially tagged chimeras. All tagged chimera transporters were 
cloned into the expression vector pCMV. 
GLUT1N has the sequence YPYDVPDYA inserted after the first methio- 
nine. GLUT4N has the sequence AYPYDVPDYA inserted after the first me- 
thionine. Exofacially tagged chimera transporters containing GLUT1  se- 
quences in the NH2 terminus have the sequence IDYPY-DVPDYA inserted 
between amino acids 53 and 54, in the predicted first exofiteial loop. Trans- 
porters with GLUT4 NH2 termini have the sequence IDYPYDVPDYA  in- 
serted between amino acids 83 and 84. Domain switches were detailed in 
the legend of Fig.  1. 
Transient Expression of  HA-Epitope-tagged Chimera 
Transporter cDNAs in COS-7 Cells 
COS-"/cells were seeded at 100,000 cells per 22-mm round, glass coverslip 
and transfection of HA epitope-tagged chimera transporter cDNAs was 
performed by the calcium phosphate precipitation method as described 
(Gorman, 1985) or by the use of  the lipofection  reagent DOTAP (Boehringer 
Mannlaeim Biochemicals) according to the recommended protocol. Cells 
were analyzed by immunotluorescence 48 h later. 
Stable Expression of Chimera Transporter cDNAs in 
CHO-KI Cells 
Subconfiuent CHO-KI cells were co-transfected  with pRSVneo and chimera 
transporter cDNAs by the calcium phosphate method described. G418- 
resistant colonies were picked up with the use of cloning cylinders and ex- 
panded. Positive cell lines were identified using immunofluorescence with 
anti-HA or anti-GLUT4 antibodies. Expression was confirmed by Western 
blotting of total cellular membranes. 
Immunofluorescence of Transfected Cells 
48 h after transfection, COS-7 cells were washed three times in PBS (171 
mM NaCI,  10 mM Na2HPO4,  3.3 mM KC1, 1.8 mM KI-I2PO4), fixed for 
10 min at room temperature in 4%  formaldehyde in PBS, and rewashed 
three times in PBS. The fixed cells were then incubated with PBS containing 
1% FBS and anti-HA antibody (mouse monoclona112CA5; BAbCO, Berke- 
ley, CA) diluted 1:1,000, for 2-3 h at room temperature. The cells were 
washed and bound primary antibody was detected with FITC-coupled goat 
anti-mouse IgG for 30 min at room temperature. After washing, the cells 
were postfixed with 4 % formaldehyde in PBS for 5 min at room tempera- 
ture. Cells were then permeabilized by incubating with PBS containing 1% 
FBS and 0.5% Triton X-100 for 30 min at room temperature. Cells were 
then incubated with a  1:1,000 dilution of either rabbit anti-GLUT4 IgG 
(R1288) or monoclonal anti-HA antibody (12CA5) depending on the COOH- 
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washed, and bound primary antibodies detected with a  l:l,000 dilution of 
rhodamine-coupled goat anti-rabbit or anti-mouse IgG (Tago, Inc., Burlin- 
game, CA). The cells were thoroughly washed and the coverglasses were 
mounted in 90%  glycerol +  2.5%  DABCO. 
Samples were visualized on a  microscope (IM-35;  Carl  Zeiss, Ober- 
kochen, Germany), using a Nikon Apo 60/1.4  oil immersion lens. Images 
were recorded using a  thermoelectrically cooled charged-couple device 
camera (Photometrics Ltd., Tucson, AZ).  CHO-KI cell lines were ana- 
lyzed by immunofluorescence  essentially as described above, except that the 
cells on coverslips were permeabilized directly after fixation and total cellu- 
lar staining was detected with anti-HA antibody or anti-GLUT4 antibody 
(R1288)  as  necessary.  Primary  antibodies  were  detected  with  FITC- 
conjugated goat anti-mouse or goat anti-rabbit second antibodies as above. 
Results 
Exofacial HA Epitope-tagged  GLUTI Is Bound by 
Antibody 12CA5 in Intact Cells 
As a means of assessing the concentrations of glucose trans- 
porters at the cell surface membrane, we devised a strategy 
to confer a known antibody recognition site on the predicted 
exofacial loops of these proteins. To achieve this objective, 
cDNA  constructs  encoding  HA-tagged  GLUTI,  GLUT4, 
and the GLUT1/GLUT4 chimera transporters were prepared 
as depicted schematically in Fig.  1. DNA encoding the nine 
amino  acid  HA  epitope  sequence YPYDVPDYA  was  in- 
serted into the GLUT1 exofacial loop or into the GLUT4 ex- 
ofacial  loop.  Chimera  GLUTI/GLUT4 cDNA  constructs 
containing these exofacial loop HA inserts were then en- 
gineered as indicated. In addition, GLUTI and GLUT4 con- 
structs were prepared containing HA epitope tags at their 
NH2 termini, which are predicted to extend into the cyto- 
plasmic domain (GLUT1N and GLUT4N in Fig.  1).  The 
cDNA constructs were then ligated into the expression vec- 
tor pCMV and used for transient expression in COS-7 cells 
(see Figs. 2-5).  Some of these constructs were also stably 
transfected into CHO cells (see Fig. 6). Insertion of the HA 
epitope into the GLUT1 structure at either the NH2 termi- 
nus or exofacial loop did not disrupt function because CHO 
cells overexpressing these proteins exhibited the expected in- 
crease in glucose transport activity (data not shown). Previ- 
ous data has also demonstrated that GLUT1/GLUT4  chimera 
constructs are functional as defined by ability to transport 
glucose (Pessino et al.,  1991;  Asano et al.,  1992).  Fig.  1 
summarizes  the cellular distributions observed with these 
expressed constructs, as described in detail below. 
The HA-tagged glucose transporter proteins depicted in 
Fig.  1 were transiently expressed in COS-7 cells. The cell 
surface concentration of each construct was analyzed by im- 
munofluorescence microscopy of non-permeabilized cells 
using a monoclonal anti-HA epitope antibody (12CA5) fol- 
lowed by a  FITC-coupled anti-mouse secondary antibody. 
Subsequently, the cellular localization of all expressed trans- 
porters in the same cells was determined by permeabilization 
with 0.5% Triton X-100, a second exposure to the same pri- 
mary  antibody,  and  then  incubation  with  a  rhodamine- 
coupled anti-mouse secondary antibody. Fig.  2  shows the 
expected divergent cellular disposition of the NH2-terminal 
(GLUT4N)  and  exofacial  (GLUT4X)  HA-tagged  native 
GLUT4  vs.  the  NH2-terminal  (GLUTIN)  and  exofacial 
(GLUTIX) HA-tagged native GLUT1  in fixed, permeabi- 
lized  COS-7  cells  (top). GLUT4N and  GLUT4X exhibit 
EXOFACIAL  CYTOPLASMIC  CELLULAR 
DmTSXS~ON 
GLUTIX  CELL SURFACE 
GLUT1N  N ~  C  CELL  SURFACE 
1M4  N ~  C  CELL  SURFACE 
215 
1/4LL  N ~  C  CELL  SURFACE 
~  VF'/T,VSVLL  ~ 
4(1-479)/1  N-'~  D  C  PARTLY  CELL SURFACE 
1(1-462)/4  N~/[~[~C  MOSTLY  INTRACELLULAR 
480 
1(1-199)/4  N -~[[[[[[[[[[[~[[[[[~  C  MOSTLY 
INTRACELLULAR  216 
1(1-53)/4  N ---El  ]-- c  INTRACELL~ 
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GLUT4N  N-J~  ~'-C  INTRACELLULAR 
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HA 
EPITOPE: YPYDVPDYA 
Figure 1. HA epitope-tagged chimeras and their comparison with 
GLUT1 and GLUT4 sequences. The location of the HA-tag is indi- 
cated by the hatched areas at the NH2 terminus or in the exofacial 
loop. GLUT1N  has the HA sequence YPYDVPDYA inserted im- 
mediately after the methionine start codon. GLUT4N has the se- 
quence AYPYDVPDYA following the first methionine. HA tags in 
the exofacial loop of chimeras containing GLUTI sequences in the 
NH2 terminus have the tag IDYPYDVPDYA inserted after amino 
acid 53. Exofacial HA tags in chimeras containing GLUT4 NH2 
termini have the epitope IDYPYDVPDYA inserted after amino acid 
83. The amino acids I and D are added to insert a unique ClaI re- 
striction site to confirm orientation. Chimera 1M4 contains amino 
acid 1-199  of  GLUT1, the amino acids 215-295 from GLUT4 corre- 
sponding to the middle loop, and GLUTI amino acids 280-492. 
GLUTI/4LL contains the amino acid sequence of GLUT1 except 
that GLUTI amino acids 319 to 327 have been replaced with amino 
acids 335-343 from GLUT4. Chimera 1(1-462)/4 replaces the last 
29 amino acids of GLUTI with the corresponding 30 amino acids 
of GLUT4.  Chimera  1(1-199)/4 contains  amino  acids  1-199 of 
GLUTI and amino acids 216-509 of GLUT4 which correspond to 
the rest of the molecule. Chimera  1(1-53)/4 contains the first 53 
amino acids of GLUTI, the HA epitope and amino acids 66-509 
of GLUT4. 
a  highly  concentrated  perinuclear  localization,  whereas 
GLUTIN and GLUT1X are readily detected at the cell bor- 
der as well as in the perinuclear region. These patterns of 
distribution were identical to those observed with native, un- 
tagged GLUT4 and GLUT1, detected with their respective 
anti-COOH-terminal peptide antibodies, following expres- 
sion in COS-7 cells (not shown). 
To directly determine the levels of expressed transporter 
proteins on the cell surface, binding of anti-HA epitope anti- 
body to non-permeabilized COS-7 cells was examined. As 
expected, exofacial HA epitope-tagged GLUTIX was readily 
detected under these non-permeabilized conditions (Fig. 2, 
bottom) in the same cells found to express this protein by 
labeling after permeabilization (Fig. 2, top). No signal was 
observed in non-permeabilized COS-'/cells expressing the 
GLUT4N, GLUT1N, or GLUT4X, as predicted by either the 
cytoplasmic  disposition  of  the  HA  tag  (GLUT4N  and 
GLUT1N) or by the intracellular localization of the trans- 
porter proteins  (GLUT4X).  Taken together,  these results 
confirm the utility of this experimental strategy using exofa- 
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cence  microscopy  of  HA- 
tagged  GLUT1 and  GLUT4 
transporters  transiently  ex- 
pressed in COS-7 cells. COS-7 
cells  transiently  transfected 
with the indicated constructs 
were  fixed in 4%  formalde- 
hyde 48 h after transfeetion. 
Cell surface  transporters (SUR- 
FACE)  were  detected  by 
incubation with anti-HA anti- 
body  (12CA5), and  FITC- 
conjugated  goat  anti-mouse 
IgG before permeabilization. 
The cells were then permeabi- 
lized and total cellular trans- 
porters  (TOTAL) were  de- 
tected with anti-HA antibody 
and  rhodamine-coupled goat 
anti-mouse (GLUTI) or anti- 
GLUT4 antibody (R1288) and 
rhodamine-eoupled goat anti- 
rabbit  antibodies  (GLUT4). 
Bar, 10/~m. 
cial HA epitope tagging to determine the cell surface local- 
ization of glucose transporters. 
The Variable COOH-terminal Cytoplasmic 
Domain Is a Major Determinant of  Glucose 
Transporter Localization 
Using the above methodology, the extent to which extreme 
COOH-terminal  sequences  on  the  glucose  transporters 
influenced cellular localization was  evaluated.  Continuing 
from the last COOH-terminal membrane spanning segment, 
the first  11  amino acid  residues of the predicted COOH- 
terminal cytoplasmic tails of GLUT1 and GLUT4 are highly 
similar (,x,80%  sequence identity), whereas the remaining 
COOH-terminal tail residues are quite dissimilar (m20 % se- 
quence identity). These divergent COOH-terminal residue 
segments  on the  GLUTI  and  GLUT4 proteins have been 
switched in constructs 4(1-478)/1 and 1(1-462)/4 (see Fig. 1). 
In  this  series  of  experiments,  the  exofacial  HA-tagged 
GLUT1X and GLUT4X also displayed the usual cell surface 
and perinuclear dispositions, respectively (Fig. 3). Remark- 
ably,  substituting  the  COOH-terminal  30  amino  acids  of 
GLUT4 onto GLUT1 (111-462]/4) caused a perinuclear local- 
ization of the chimera, as visualized in permeabilized cells 
(Fig.  3,  top). When non-permeabilized COS-7  cells were 
analyzed  with  the  12CA5  antibody,  GLUTIX-expressing 
cells were readily observed, whereas no signal above back- 
ground was detected in cells expressing the 1(1-462)/4 glu- 
cose transporter construct (Fig.  3,  bottom). Chimera  1(1- 
Figure  3.  Immunofluores- 
cenee  microscopy  of  HA- 
tagged GLUTI, GLUT4, and 
three  transporter  chimeras 
transiently expressed in COS-7 
cells. COS-7 cells transiently 
transfected with the indicated 
constructs  were  fixed in 4% 
formaldehyde  48 h after trans- 
fection.  Cell  surface  (SUR- 
FACE) and total (TOTAL)  im- 
munoreactivity was analyzed 
as described in the legend to 
Fig.  2. Bar, 10/~m. 
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level on cell surface localiza- 
tion of GLUT1, GLUT4, and 
three  transporter  chimeras 
transiently  expressed in COS-'/ 
cells. COS-7 cells transiently 
transfeeted with the indicated 
constructs were fixed in 4% 
formaldehyde  48 h after trans- 
fection.  Cell  surface  (SUR- 
FACE) and total (TOTAL) im- 
munoreactivity was analyzed 
as described in the legend to 
Fig. 2. Two different levels of 
expression of each construct 
were analyzed. Top panels of 
both galleries represent ceils 
with  low  expression levels, 
whereas  bottom  panels  in 
both galleries represent cells 
with higher expression levels. 
Bar, 10 ~tm. 
199)/4 containing the NH2-terminal  199 residues of GLUT1 
and the remaining COOH-terminal residues of GLUT4 also 
exhibited  an  intracellular localization when expressed  in 
COS-7 cells (Fig. 3). 
A chimera in which the 29 COOH-terminal residues of 
GLUT1  were  substituted  onto  GLUT4  (411-478]/1) con- 
firmed the importance of the variable COOH-terminal se- 
quences  of GLUT1  and  GLUT4  in  determining whether 
these proteins distribute significantly to the plasma mem- 
brane.  Thus,  the 4(1-478)/1  protein  was readily observed 
when analyzed in non-permeabilized COS-7  ceils with the 
12CA5 antibody (Fig. 3, bottom), and displayed an overall 
distribution  pattern  that  resembled  native  GLUT1  when 
visualized in permeabilized cells (Fig. 3, top). Comparison 
of the intensity of cell surface staining of GLUTIX vs. 4(1- 
478)/1  at similar levels of total transporter expression indi- 
cated the former achieves a higher concentration at the cell 
surface.  This  suggests that other  structural elements may 
also play a significant role in glucose transporter membrane 
distribution.  Taken together,  the  data  in  Fig.  3  reveal  a 
heretofore unrecognized major cell localization determinant 
in the COOH-terminal region of the GLUT1 and GLUT4 
transporter proteins. 
A  Transporter Domain between the 
Exofacial and ExtraceUular Loops Influences 
Cellular Localization 
The  similar  intracellular localization patterns  of the  1(1- 
199)/4 and 1(1-462)/4 glucose transporter chimeras shown in 
Fig. 3 contrast sharply with the observations made by other 
laboratories. Asano et al. (1992) found a partial intracellular 
localization displayed by a chimera similar to our 1(1-199)/4, 
but extreme COOH-terminal cytoplasmic sequences did not 
influence transporter localization in their studies. Piper et al. 
(1992)  reported a  similar lack of effect of these latter se- 
quences. We therefore tested whether the extent of total glu- 
cose transporter protein expression in COS-7  cells might 
influence the apparent cellular localization of transporters. 
The presently developed methodology allows us to rigor- 
ously compare both total expression levels  of transporters 
and the concentration of these proteins on the cell surface. 
Fig. 4 depicts the results of experiments in which the cell 
surface concentration of transporters was analyzed in COS-7 
cells expressing either high or low amounts of total heterolo- 
gously expressed  transporter  protein.  Cells  were  chosen 
based on their immunofluorescence intensity after permea- 
bilization and staining with 12CA5 and rhodamine-tagged 
anti-mouse Ig. The cell surface concentration of HA-tagged 
transporter was then determined by visualizing fluorescence 
from the FITC-labeled anti-Ig antibody, which reflects the 
anti-HA antibody bound to cells before permeabilization. 
COS-7  cells expressing low amounts of HA-tagged trans- 
porter protein showed completely intracellular distributions 
of GLUT4X and the three chimeras containing GLUT1 and 
sequences towards the COOH-terminal cytoplasmic tall of 
GLUT4 (111-462]/4, 111-199]/4, or 1[1-53]/4), as assessed by 
the lack of FITC staining. In contrast, cell surface GLUT1X 
was readily observed under these conditions (Fig. 4, panels 
SURFACE, low). The results confirm those of Fig.  3, and 
reinforce the lack of detectable influence of extreme NH2- 
terminal sequences  in governing intracellular localization 
(constructs 111-53]/4 vs.  GLUT4X). 
In contrast,  similar analysis of COS-7  cells expressing 
high concentrations of  these constructs revealed the presence 
of chimeras 1(1-462)/4 and 1(1-199)/4 on the cell surface, but 
not of  1(1-53)/4 or  GLUT4X  (Fig.  4,  panels  SURFACE, 
high). These results indicate that GLUT4 sequences 66-216 
or the corresponding region of GLUT1, contain structural 
elements that may also play a role in the cellular localization 
of GLUT1 and GLUT4, in agreement with the conclusion of 
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I/M4 and 1/4LL  transiently expressed in COS-7 cells. COS-7 cells 
transiently transfected with the indicated constructs were fixed in 
4 % formaldehyde  48 h after transfection, and analyzed as described 
in Fig. 2. 
Asano  et  al.  (1992).  In  these  present  experiments,  the 
influence of these sequences only becomes evident at high 
levels of glucose transporter expression. 
The analysis depicted in Fig. 4 also appears to confirm the 
finding  of  Asano  et  al.  (1992)  that  the  extreme  NH2- 
terminal residues of GLUT4 fail to effect membrane distri- 
bution of this transporter protein. Experiments were also un- 
dertaken  to  examine the  possible  influence of the major 
GLUT4 intracellular loop on cellular localization of glucose 
transporters. A GLUT1 construct (l/M4) with this GLUT4 
middle loop substitution was expressed in COS-7  cells and 
found to distribute in a manner identical to native GLUT1 
when probed with 12CA5  antibody following fixation and 
permeabilization of the cells (Fig. 5, panel TOTAL). Cell sur- 
face display of this chimera was confirmed by detection of 
intense fluorescence images when non-permeabilized COS-'/ 
cells  were  analyzed  (Fig.  5,  panel  SURFACE).  Similar 
findings were made using a  GLUTI construct (see  1/4LL 
construct in Fig. 1) in which the sequence of the seventh in- 
tracellular loop of GLUTI was substituted for that of GLUT4 
(Fig. 5). These results indicate that the GLUT4 sequences 
present in the fifth and seventh intracellular loops do not ap- 
pear to influence transporter localization. 
GLUT4 COOH-terminal Domain Also Confers a 
Perinuclear Localization in CHO Cells 
A  plausible  explanation  for  the  differences between  our 
findings indicating a key role in membrane trafficking for the 
cytoplasmic COOH-terminal tail domain of transporter pro- 
teins and those of  others is the use of  ditferent cell types. Nei- 
ther of the previous reports using transporter chimeras de- 
scribed experiments with COS cells, while both Piper et al. 
(1992) and Asano et al. (1992) used CHO cells for analysis 
of transporter localization. Therefore, in the present studies 
CHO cells were stably transfected with native GLUT1 and 
GLUT4 constructs, GLUTIX and GLUT4N, and chimera 
1(1-199)/4 depicted in Fig. 1. Stably transfected cell lines ex- 
pressing a chimera 1(1-462)/4 containing GLUT1 sequences 
except for the 30 amino acid COOH-terminal GLUT4 do- 
main substitution (as in Fig. 1, but without the HA tag) were 
also  developed.  Analysis of GLUT4N  and  chimera  1(1- 
199)/4  localization with 12CA5 antibody in the transfected 
CHO  cells  after  fixation and  permeabilization showed  a 
marked perinuclear concentration (Fig. 6),  similar to that 
observed for these transporters in COS-7  cells (Figs. 2-4). 
Interestingly, GLUTIX displayed a distribution pattern that 
was almost exclusively localized to the cell periphery, with 
very little intracellular staining in these CHO cells (Fig. 6). 
In contrast, the 1(1-462)/4 chimera composed of GLUT1 se- 
quences except for the extreme 30-residue GLUT4 COOH- 
terminal substitution displayed an intracellular, perinuclear 
distribution. Interestingly, at high levels of expression, this 
transporter chimera was also detected at the cell surface. 
These results confirm the findings made with similar glucose 
transporter chimera proteins expressed in COS-7 cells (Figs. 
2-4),  and define the variable COOH-terminal domain of 
these transporters as a critical determinant of cellular local- 
ization. 
Discussion 
A New Methodology to Quantify Cell 
Surface Transporters 
A major objective of  the present studies was the development 
of methodology able to provide direct, unambiguous assess- 
ment of  glucose transporter proteins at the cell surface mem- 
brane. Such a technique could be used to quantify cell sur- 
face  localization  of  glucose  transporters,  calculate  the 
specific catalytic activity of transporter proteins, and pro- 
vide  information on  the  underlying cellular mechanisms 
responsible for acute redistribution of transporters to the 
plasma membrane in response to insulin. Previous attempts 
to estimate cell surface glucose transporter proteins quan- 
titatively have been met with several obstacles. For example, 
immunoelectron microscopy has been used successfully to 
document insulin-mediated increases in glucose transporter 
protein in the vicinity of the plasma membrane (Blok et al., 
1988; Slot et al., 1991; Smith et al., 1991), but the resolution 
obtained  does  not  permit  rigorous  conclusions  about 
whether transporter proteins are actually exposed to the ex- 
tracellular space.  Furthermore, the possibility that insulin 
action  changes  the  accessibility  of  antibodies  directed 
against the COOH-terminal cytoplasmic tail of GLUT4 in 
such studies has been  raised  (Smith et al.,  1991). These 
problems  similarly  complicate  standard  immunofluores- 
cence microscopy techniques. 
Another method recently developed to detect exposed cell 
surface GLUT1  and GLUT4 involves affinity labeling the 
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and two transporter chimeras stably expressed in CHO cells. CHO- 
K1  cells  stably  expressing GLUT4N,  GLUT1X, HA-tagged 1(1- 
199)/4, and two lines of untagged 1(1-462)/4 expressing the con- 
struct at low and high levels were grown on coverslips. The cells 
were fixed, permeabilized with PBS  + 1% FBS  +0.5 % Triton X-100, 
and  expression  detected  with  antibodies  against HA  (GLUT1, 
GLUT4, 111-199]/4)  or against a COOH-terminal GLUT4 peptide 
(1(1-462)/4). Primary  antibodies  were  detected  with  FITC con- 
jugated anti-mouse  or anti-rabbit  antibodies. Images represented 
total staining within the cell. 1(1-462)/4  clone A is a low expressing 
cell line, 1(1-462)/4 clone B is a high expressing cell line. Arrow- 
heads mark intracellular staining in 1(1-462)/4  clone B. Bar, 10/xm. 
glucose transporters on intact cells with photoactive man- 
nose (Holman et al.,  1990) or glucose (Jhun et al.,  1992) 
analogs. These agents react with the transporter proteins at 
glucose binding  sites that operate as part of the transport 
catalysis mechanism. However, the use of these photolabel- 
ing agents for quantitative measurements may be inappropri- 
ate because they are based on the assumption that the proper- 
ties  of these  sites  do  not  change  under  different cellular 
conditions. Recent results suggest that in certain situations 
transporter glucose binding sites are inhibited or occluded 
by unknown cellular mechanisms  (Harrison et al.,  1992). 
Thus, alternative ways of assessing the concentration of cell 
surface glucose transporters are needed. 
Insertion of the HA epitope into the predicted exofacial 
loops of GLUT1 and GLUT4 as a means of monitoring ex- 
posure of the tagged transporters to the extracellular space 
is documented by the present studies. This method provides 
unambiguous  results,  provided the  surface membranes  of 
cells analyzed are intact and impermeable to anti-HA immu- 
noglobulin  added  to  the  medium.  Thus,  exofacial  loop- 
tagged GLUT1X is intensely stained with antibody on the 
surface  of  transfected,  non-permeabilized  COS-7  cells, 
whereas GLUT-1 containing the HA tag on its cytoplasmic 
NH2 terminus (GLUT1N) is not visualized under these con- 
ditions (Fig.  2).  This latter construct serves as a  valuable 
control for the possibility that processing the cells in any 
given experiment permeabilizes the plasma  membrane to 
anti-HA antibody. It should be noted that  12CA5  antibody 
binding to intact cultured cells can also be performed prior 
to fixation and analysis in order to assess cell surface trans- 
porters (data not shown). Other advantages of this technique 
include  the  high  affinity  of  the  commercially  available 
12CA5  antibody and the ability to assess transporter local- 
ization following transient transfection, when only a small 
percentage of  cells express the desired transporter construct. 
Further, endogenous transporter proteins are not visualized 
in the assay because they lack the HA epitope. Thus, the new 
methodology is  a  highly  specific and  sensitive means  to 
evaluate  surface  localization  of specific  transporter  con- 
structs in many different cell types, 
The exofacial HA epitope-tagging method used here also 
reveals  major  limitations  in  the  use  of  standard  im- 
munofluorescence  microscopy for assessing cell surface pro- 
teins. Antibody staining in regions near the cell periphery 
can be easily mistaken for actual cell surface localization. 
For example, high levels of expression of chimera 1(1-53)/4 
in permeabilized COS-7 cells causes intense staining with 
the  12CA5  antibody extending to areas  along the plasma. 
membrane (Fig. 4, panel TOTAL, high).  However, in non- 
permeabilized COS-7 cells transfected with this construct, 
no cell surface binding to anti-HA antibody is detected. In 
contrast,  1(1-462)/4  transporter,  which  displays  a  similar 
staining pattern to 1(1-53)/4 in permeabilized COS-7 cells, 
is readily detected in non-permeabilized cells as well (Fig. 
4). Thus, the HA-tagging method is able to document plasma 
membrane localization of transporter constructs even when 
this is difficult by the standard immunofluorescence micros- 
copy techniques used by other investigators. 
Glucose Transporter Domains Governing 
Cellular Localization 
The present studies designed to assess  actual exposure of 
glucose transporter chimeras on the cell surface have re- 
vealed  the  COOH  terminus  as  a  major  structural  deter- 
minant of transporter localization in COS-7 and CHO cells. 
This  finding  was  unexpected  because  two  independent 
laboratories have previously concluded that this domain is 
not involved in directing the cellular distribution of glucose 
transporters (Piper et al., 1992; Asano et al., 1992). It is all 
the more surprising because we were easily able to detect a 
striking  effect using  standard  fluorescence microscopy by 
switching COOH termini on GLUT1 and GLUT4 chimera 
constructs. Detecting the HA epitope of the 4(1-478)/1  chi- 
mera on the cell surface of nonpermeabilized cells unequivo- 
cally confirmed the observations (Figs.  3 and 4).  It is not 
clear  why  previous  investigations  failed  to  discover  this 
effect. Both previous studies used CHO cells, as we did in 
the experiments depicted in Fig. 6. However, that levels of 
heterologous  glucose  transporter  expression  were  much 
higher in the previous studies seems a likely possibility to 
consider. Piper et al. (1992) used a recombinant Sindbis viral 
vector to drive expression of glucose transporter chimeras 
in CHO-K1 cells to very high levels (equivalent to primary 
adipocyte content of GLUT4 after only 2  h  of infection). 
Asano et al. (1992) used CHO-K1 cells exhibiting somewhat 
lower levels of heterologous transporter expression, and ob- 
tained consistent results in at least three cell clones for each 
chimera. Nevertheless, it is not clear from their data whether 
expression levels were similar to or higher than ours. 
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cell surface concentration of glucose transporter chimeras 
was the increment in cellular deoxyglucose uptake over that 
of parental cells. These investigators observed high hexose 
uptake rates in CHO cells expressing a transporter chimera 
in which a  COOH-terminal portion of GLUT4 was  sub- 
stituted onto GLUTI. In the present studies, stably trans- 
fected CHO cells expressing chimeras  1(1-199)/4 and 1(1- 
462)/4  also exhibited elevated hexose uptake rates, as we 
previously reported (Pessino et al., 1991), even though these 
chimeras  exhibit  a  predominant  perinuclear  localization 
(Fig. 6). A plausible reason for this apparent paradox is that 
high levels of transporter expression saturate those mecha- 
nisms which prevent GLUT4 from accumulating at the cell 
surface. The marked contrast in staining pattern between na- 
tive  GLUT1,  which  localizes  almost  exclusively  to  the 
plasma membrane, vs.  1(1-199)/4 or 1(1-53)/4 which display 
an intense perinuclear presence, is striking in our experi- 
ments (Fig. 6).  Nevertheless, at relatively high expression 
levels, significant amounts of these chimera proteins also ac- 
cumulate on the cell surface, leading to increased deoxyglu- 
cose uptake. Taken together, the results from the previous 
studies and the present work suggest the following model: at 
physiological or  lower levels  of GLUT4  expression,  the 
COOH-terminal  cytoplasmic domain  contains  the  major 
structural motif that determines intracellular localization. 
The influence of this motif saturates in this range of total 
transporter expression, whereas another structural element 
between the exofacial and intracellular loops has an effect 
that maintains the intracellular concentration of transporter 
even at higher levels of expression (e.g., Fig. 4). 
Recent findings indicate that GLUT1 is present in intact 
cells, self-associated in oligomeric structures (Pessino et al., 
1991). This is evidenced by co-immtmoprecipitation of en- 
dogenous  GLUTI  with  chimera  1(1-462)/4  expressed  in 
CHO cells using anti-COOH-terminal GLUT4 peptide anti- 
body. Co-precipitation of native GLUT1 and native GLUT4 
is  not observed under similar conditions (Pessino et al., 
1991).  In  purified  form,  the  GLUTI  protein  apparently 
forms dimers or tetramers (Hebert and Carruthers,  1991; 
Hebert and Carruthers,  1992).  These observations poten- 
tially  complicate  interpretations  on  the  behavior  of ex- 
pressed transporter chimeras due to their possible associa- 
tion  with  endogenous  transporter  proteins.  Thus,  it  is 
possible that chimera trafficking  patterns simply reflect their 
ability to oligomerize with and be directed by endogenous 
transporter  proteins.  However,  it  would appear  that this 
problem does not apply to our major observation implicating 
the COOH terminus as a key determinant of cellular local- 
ization. Thus, the 1(1-462)/4 chimera displays an intracellu- 
lar concentration (Fig. 3) despite the absence of endogenous 
GLUT4 in COS-'/or CHO cells. Furthermore, the 4(1-478)/1 
chimera, present on the cell surface, does not contain the 
GLUT1 residues 1-199 that appear to be necessary for oligo- 
merization with endogenous GLUT1 (Pessino et al., 1991). 
It is also unlikely that the purported influence of residues be- 
tween the major exofacial and cytoplasmic loops in cellular 
distribution is related to oligomerization of 1(1-199)/4 with en- 
dogenous GLUTI (Fig. 4). This is because this chimera dis- 
plays predominantly intracellular pattern even at expression 
levels that are much higher than the endogenous GLUT1 
protein. 
The COOH-terminal cytoplasmic domains of GLUT4 and 
GLUT1 could operate to confer the characteristic cellular 
distributions of  these proteins through several types of  mech- 
anisms.  One  possibility  is  that  the  COOH  terminus  of 
GLUTI contains information that drives its movement to the 
cell surface. Alternatively, the COOH-terminal domain of 
GLUT4 may contain information that confers its intracellu- 
lar localization. This latter possibility is favored by substan- 
tial evidence indicating that movement of proteins through 
the secretory pathway to the plasma membrane occurs by de- 
fault. According to this concept, no specific structural sig- 
nals  are  required  for  the  progression  of proteins  to  the 
plasma membrane. In contrast, proteins that do not reach the 
cell surface immediately after synthesis (i.e., GLUT4) usu- 
ally have specific structural elements that target the protein 
to  a  functionally  relevant  compartment.  Signals  in  the 
COOH-terminal domain of GLUT4 could determine its in- 
tracellular localization by several conceivable mechanisms. 
For example, the signal could direct the transporter to a 
specialized intracellular vesicle following its synthesis and 
processing. Alternatively, the transporter might first reach 
the plasma membrane, and then be directed by an endocyto- 
sis pathway to a particular intracellular membrane pool. In- 
terestingly, this mechanism appears  to be involved in the 
synthesis of small  synaptic vesicles  in  PC12  cells  (Reg- 
nier-Vigouroux et al.,  1991). 
Analysis  of the  primary  amino  acid  sequence  of the 
GLUT4 COOH  terminus reveals  features that potentially 
contain targeting  information.  Residues  489  and 490  of 
GLUT4 are leucines, resembling dileucine motifs recently 
found to be important in the targeting of T cell receptor CD3 
chains (Letourneur and Klausner, 1992) and in the sorting 
of the IGF-IUmannose-6-phosphate receptor to a prelyso- 
somal/lysosomal  pathway (Johnson and Kornfeld, 1992). In- 
terestingly, the dileucine motif alone appears to efficiently 
target proteins to the endocytic pathway. Fig. 5 shows that 
a dileucine motif  near the major intracellular loop has no de- 
tectable influence on glucose transport localization, and fu- 
ture work is devoted to similar evaluation of the COOH- 
terminal dileucine. Sequences contained between residues 
53 and 199 of GLUT4 also appear to contribute to its intra- 
cellular localization. It is interesting that even at high levels 
of expression, chimeras containing such sequences are not 
expressed at the cell surface (Fig. 4). The additive effects of 
the 53-199 and the COOH-terminal regions suggest the exis- 
tence of at least two independent retention/internalization 
determinants in GLUT4. An important future goal is to fur- 
ther define the structural nature of each determinant, and to 
explore whether the actions of insulin on the distribution of 
GLUT4 are exerted through the interactions of these deter- 
minants with the trafficking machinery of insulin-sensitive 
cells. 
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